Prior Authorization
Requiring prescribers to obtain advance approval before insurance will cover HCV treatment
Find your state below and read our 2022 National Summary Report.
While there have been some improvements in both state Medicaid program transparency and access since 2014, most states still have discriminatory restrictions that keep patients from being cured.
To learn more about these restrictions, watch our webinar from June 2022.
Requiring prescribers to obtain advance approval before insurance will cover HCV treatment
Based on a patient’s degree of liver damage or fibrosis level
Based on a patient’s drug or alcohol use
Based on a prescriber’s specialty or expertise
Based on whether a patient has previously received treatment
Assesses parity between a state’s fee-for-service program and contracted managed care organizations
Restrictions that are less common but may pose severe barriers to care
*States with an asterisk next to their grade have removed prior authorization for most patients entirely
@2023 HEPATITIS C: STATE OF MEDICAID ACCESS